Because it was technically difficult to isolate the low frequent Lin−Sca-1+Kit+ cells from these tumors, we isolated hematopoietic cells from LL2 tumor stroma or host PB as a control and co-injected them with GFP+LL2 tumor cells into secondary mice. This evidence concerns the gene KIT and neoplasm.